Nutricia's Chief Medical Officer, Rolf Smeets, joins Prismic's Advisory Board - kcentv.com - KCEN HD - Waco, Temple, and Killeen

Nutricia's Chief Medical Officer, Rolf Smeets, joins Prismic's Advisory Board

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Prismic Pharmaceuticals, Inc.

SCOTTSDALE, Ariz., May 6, 2014 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., the Scottsdale, Arizona-based pharmaceutical company, today announced that Rolf Smeets, Ph.D., Chief Medical Officer for Nutricia Advanced Medical Nutrition, has joined Prismic's International Advisory Board. Nutricia Medical is a healthcare division of the Danone company.

Dr. Smeets is a member of Nutricia's Senior Management team, and has extensive experience and expertise in the areas of prescription Medical Foods, Foods for Special Medical Purposes, Functional Foods, and Nutritional Supplements. His responsibilities include the initiation and management of clinical trials, scientific, regulatory, and public affairs, as well as health economics and education. He also represents Nutricia Medical in its dealings with regulatory bodies in Europe and Asia as well as representing the company in the various Medical Nutrition Industry trade associations around the world.

On accepting Prismic's invitation to join its International Board of Advisors, Rolf Smeets said, "I am very pleased to be joining Prismic's International Board of Advisors. I see Prismic Pharmaceuticals as an innovative young company with an extremely interesting portfolio of products and a very experienced Management team and Board of Directors. I believe that the commercial and clinical concepts that Prismic is developing in the areas of nephrology, ophthalmology, and central nervous system disorders will clearly bring important health benefits to very large patient populations, and particularly to the so-called "baby boomers" in many countries. As a relatively young company, Prismic is also further differentiated by the fact that it has global reach, and is already in the process of setting-up licensing deals and commercial partnerships for its products in many countries."

Peter Moriarty, Prismic's Chairman and Chief Executive Officer, commented, "We are delighted that Rolf Smeets has accepted the invitation to join our International Board of Advisors. We are also very grateful to Nutricia Medical for allowing Rolf to be able to do this. Rolf will be a great asset to our Board, bringing exceptional knowledge and expertise to assist us in further growing our business in the USA and internationally. I would also like to take this opportunity of clarifying that Prismic's relationship is with Dr. Smeets and not with the company that employs him. Prismic Pharmaceuticals does not currently have any commercial relationship with Nutricia or its parent company, Danone."

About Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc., is a privately held pharmaceutical company focused on the development and marketing of prescription medical foods for the clinical dietary management of disorders associated with the aging population, particularly where inflammation is involved. The company is based in Scottsdale, Arizona, and was founded in 2011. Contact 480.422.1810 or visit www.PrismicPharma.com.

INFORMATION CONTACT
Peter J. Moriarty
Tel: 480.422.1810

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KCEN. All Rights Reserved. Users of this site agree to the Terms of Service, Privacy Notice/Your California Privacy Rights, and Ad Choices.